Exact Mass: 249.0907

Exact Mass Matches: 249.0907

Found 24 metabolites which its exact mass value is equals to given mass value 249.0907, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

1-(2-Pyridylazo)-2-naphthol

1-[2-(pyridin-2-yl)diazen-1-yl]naphthalen-2-ol

C15H11N3O (249.0902)


   
   

2,2:6,2-terpyridine N-oxide

2,2:6,2-terpyridine N-oxide

C15H11N3O (249.0902)


   

Bay H 2049

Daniquidone

C15H11N3O (249.0902)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor

   

1-PHENYL-3-PYRIDIN-3-YL-1H-PYRAZOLE-4-CARBALDEHYDE

1-PHENYL-3-PYRIDIN-3-YL-1H-PYRAZOLE-4-CARBALDEHYDE

C15H11N3O (249.0902)


   

ETHYL5-AMINO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-3-CARBOXYLATE

ETHYL5-AMINO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-3-CARBOXYLATE

C12H12FN3O2 (249.0914)


   

ethyl 5-amino-1-(4-fluorophenyl)pyrazole-4-carboxylate

ethyl 5-amino-1-(4-fluorophenyl)pyrazole-4-carboxylate

C12H12FN3O2 (249.0914)


   

1,3,5-Triazin-2(1H)-one, 4,6-diphenyl-

1,3,5-Triazin-2(1H)-one, 4,6-diphenyl-

C15H11N3O (249.0902)


   

ETHYL5-AMINO-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE

ETHYL5-AMINO-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE

C12H12FN3O2 (249.0914)


   

2,6-Bis(2-pyridyl)-4(1H)-pyridone

2,6-Bis(2-pyridyl)-4(1H)-pyridone

C15H11N3O (249.0902)


   

3,6-DIPHENYL-1,2,4-TRIAZIN-5-OL

3,6-DIPHENYL-1,2,4-TRIAZIN-5-OL

C15H11N3O (249.0902)


   

ETHYL5-AMINO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE

ETHYL5-AMINO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE

C12H12FN3O2 (249.0914)


   

1-PHENYL-3-PYRIDIN-4-YL-1H-PYRAZOLE-4-CARBALDEHYDE

1-PHENYL-3-PYRIDIN-4-YL-1H-PYRAZOLE-4-CARBALDEHYDE

C15H11N3O (249.0902)


   

1,2,4-Triazin-3(2H)-one,5,6-diphenyl-

1,2,4-Triazin-3(2H)-one,5,6-diphenyl-

C15H11N3O (249.0902)


   

7-(BENZYLOXY)-1H-INDAZOLE-3-CARBONITRILE

7-(BENZYLOXY)-1H-INDAZOLE-3-CARBONITRILE

C15H11N3O (249.0902)


   

1-(6-(quinoxalin-2-yl)pyridin-2-yl)ethanone

1-(6-(quinoxalin-2-yl)pyridin-2-yl)ethanone

C15H11N3O (249.0902)


   

1-(3-PHENYL-2-PROPENOYL)-1H-BENZOTRIAZO&

1-(3-PHENYL-2-PROPENOYL)-1H-BENZOTRIAZO&

C15H11N3O (249.0902)


   

2-(2-pyridylazo)-1-naphthol

2-(2-pyridylazo)-1-naphthol

C15H11N3O (249.0902)


   

4-hydroxy-2,2:6,2-terpyridine

4-hydroxy-2,2:6,2-terpyridine

C15H11N3O (249.0902)


   

5-(4-Chlorophenyl)-6-ethylpyrimidin-3-ium-2,4-diamine

5-(4-Chlorophenyl)-6-ethylpyrimidin-3-ium-2,4-diamine

C12H14ClN4+ (249.0907)


   

1-(2-Pyridylazo)-2-naphthol

1-(2-Pyridylazo)-2-naphthol

C15H11N3O (249.0902)


   

ML351

ML351

C15H11N3O (249.0902)


ML351 is a potent and highly specific 15-LOX-1 inhibitor with an IC50 of 200 nM. ML351 shows excellent selectivity (>250-fold) versus the related isozymes, 5-LOX, platelet 12-LOX, 15-LOX-2, ovine COX-1, and human COX-2[1].?ML351 prevents dysglycemia and reduces β-cell oxidative stress in nonobese diabetic mouse model of T1D[2].

   

SY-LB-35

SY-LB-35

C15H11N3O (249.0902)


SY-LB-35 is a potent bone morphogenetic protein (BMP) receptor agonist. SY-LB-35 can stimulate significant increases in cell number and cell viability in the C2C12 myoblast cell line, and causes shifts towards the S and G2/M phases of the cell cycle. SY-LB-35 stimulates canonical Smad and non-canonical PI3K/Akt, ERK, p38 and JNK intracellular signaling pathways[1].

   

1-(1h-pyrrol-2-yl)-9h-pyrido[3,4-b]indol-6-ol

1-(1h-pyrrol-2-yl)-9h-pyrido[3,4-b]indol-6-ol

C15H11N3O (249.0902)